Pleconaril

Pleconaril (Picovir) is an antiviral drug developed by Schering-Plough, now Merck. It has activity against Picornaviridae viruses including Enteroviruses and Rinoviruses.

Pleconaril has shown promise for the treatment of enteroviruses in a number of in vitro and clinical studies.

The drug was available under compassionate use until 2003 and has not been approved by the FDA.